L-R: Brian Morrissey, General Manager, Michael Gately, Head of Operations and Declan Hoare, Head of Quality meet with the ...

As AI drives seismic change across the pharmaceutical industry, its adoption is accompanied by uncertainty and risk.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Leqselvi (deuruxolitinib), made by Sun Pharma UK, as a treatment for severe alopecia areata in adults. Alopecia areata is a ...

Incyte Biosciences UK’s Opzelura (ruxolitinib) cream has been approved for reimbursement for eligible patients with ...

Inizio Ignite has made five appointments to its key leadership amid the unification of four teams, Research Partnership, ...

Johnson & Johnson’s (J&J) nipocalimab, a potential immunoselective investigational treatment for adults with systemic lupus ...

Medical Affairs is operating at a pivotal moment. Expectations have expanded rapidly – deeper scientific exchange, sharper ...

Bristol Myers Squibb’s (BMY) Sotyktu has been approved by the US FDA to treat adults with active psoriatic arthritis (PsA). The approval is based on positive results from two phase 3 trials (POETYK ...

Johnson & Johnson (J&J) has announced US FDA approval for Tecvayli (teclistamab-cqyv) plus Darzalex Faspro (daratumumab and hyaluronidase-fihj) to treat adults with relapsed or refractory multiple ...

The last patient in Lundbeck’s phase 3 clinical trial, MASCOT, has been randomised ahead of schedule in a study evaluating amlenetug as a potential treatment for multiple system atrophy (MSA). The ...

There’s a clear gap: output is rising, but engagement isn’t. This often happens because many strategies focus on HCPs’ ...

UK biotech N4 Pharma, a company developing a gene delivery system to enable advanced therapies for cancer and other diseases, ...